CTMX

CytomX Therapeutics, Inc.NASDAQHealthcare

$4.56+0.00%ClosedMarket Cap: $776.3M

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-23	Piper Sandler	—	Overweight	—
2026-03-19	Barclays	—	Overweight	—
2026-03-18	Jefferies	—	Buy	—
2026-03-18	Guggenheim	—	Buy	—
2026-03-17	Wedbush	—	Outperform	—
2026-03-16	HC Wainwright & Co.	—	Buy	—
2026-03-16	JP Morgan	—	Overweight	—
2026-02-04	Barclays	—	Overweight	—
2026-02-04	Cantor Fitzgerald	—	Overweight	—
2026-01-20	Piper Sandler	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-0.50	$18.7M	7
Sun Dec 31	$-0.43	$38.3M	5
Mon Dec 31	$-0.46	$56.1M	1
Tue Dec 31	$0.04	$196.9M	1